At Vara, we believe better breast cancer detection should be a standard offering for every woman, everywhere.
We are a European medical AI company building the infrastructure for the future of breast cancer screening, working in close collaboration with radiologists to make screening more effective and accessible.
Founded in 2018 and headquartered in Berlin on the AI Campus, Vara has grown into the market leader in Germany, now covering 50% of the entire market. We have published the world’s largest clinical trial in healthcare AI (PRAIM, published in Nature Medicine) with 463,094 women. In the study, we have demonstrated a 17.6% increase in cancer detection rate and a workload reduction by 56%.
Right now, Vara is growing globally through partners in 13 countries. We are backed by long-term oriented investors. Behind our technology is an international team of entrepreneurs, engineers and healthcare experts – all working toward one shared goal: transforming the early detection of cancer.
More at www.vara.ai.